These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 12870431)
1. siRNA-mediated antitumorigenesis for drug target validation and therapeutics. Lu PY; Xie FY; Woodle MC Curr Opin Mol Ther; 2003 Jun; 5(3):225-34. PubMed ID: 12870431 [TBL] [Abstract][Full Text] [Related]
2. Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention in a mouse model of cervical cancer. Jonson AL; Rogers LM; Ramakrishnan S; Downs LS Gynecol Oncol; 2008 Nov; 111(2):356-64. PubMed ID: 18755502 [TBL] [Abstract][Full Text] [Related]
3. Short interfering RNA (siRNA): tool or therapeutic? Cejka D; Losert D; Wacheck V Clin Sci (Lond); 2006 Jan; 110(1):47-58. PubMed ID: 16336204 [TBL] [Abstract][Full Text] [Related]
4. Advances in the development of siRNA-based therapeutics for cancer. Shen Y IDrugs; 2008 Aug; 11(8):572-8. PubMed ID: 18683092 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic potential of RNA interference against cancer. Takeshita F; Ochiya T Cancer Sci; 2006 Aug; 97(8):689-96. PubMed ID: 16863503 [TBL] [Abstract][Full Text] [Related]
6. Prolonged gene silencing in hepatoma cells and primary hepatocytes after small interfering RNA delivery with biodegradable poly(beta-amino esters). Vandenbroucke RE; De Geest BG; Bonné S; Vinken M; Van Haecke T; Heimberg H; Wagner E; Rogiers V; De Smedt SC; Demeester J; Sanders NN J Gene Med; 2008 Jul; 10(7):783-94. PubMed ID: 18470950 [TBL] [Abstract][Full Text] [Related]
7. siRNA-mediated type 1 insulin-like growth factor receptor silencing induces chemosensitization of a human liver cancer cell line with mutant P53. Niu J; Xu Z; Li XN; Han Z Cell Biol Int; 2007 Feb; 31(2):156-64. PubMed ID: 17097318 [TBL] [Abstract][Full Text] [Related]
8. RNA interference in the mouse vascular endothelium by systemic administration of siRNA-lipoplexes for cancer therapy. Santel A; Aleku M; Keil O; Endruschat J; Esche V; Durieux B; Löffler K; Fechtner M; Röhl T; Fisch G; Dames S; Arnold W; Giese K; Klippel A; Kaufmann J Gene Ther; 2006 Sep; 13(18):1360-70. PubMed ID: 16625242 [TBL] [Abstract][Full Text] [Related]
9. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA. Spagnou S; Miller AD; Keller M Biochemistry; 2004 Oct; 43(42):13348-56. PubMed ID: 15491141 [TBL] [Abstract][Full Text] [Related]
10. Oral delivery of siRNA and antisense oligonucleotides. Akhtar S J Drug Target; 2009 Aug; 17(7):491-5. PubMed ID: 19530907 [TBL] [Abstract][Full Text] [Related]